Add Formweb to your mobile device
Formulary synchronization in progress.
Please refer to Epic and your local
pharmacy
for available medications.
Search results for:
eculizumab
eculizumab
- Provider restrictions: Restricted to attending-level physicians registered with the eculizumab (Soliris®) REMS Program
- Patient restrictions: Restricted to patients who are registered with the manufacturer, Alexion Pharmaceuticals, Inc.
- Patient restrictions: Restricted to FDA-approved indications (PNH or aHUS) or for transplant patients who meet criteria according to the solid organ transplant clinical practice guideline
- Care Area restrictions: Restricted to outpatient setting with financial approval or inpatient use for emergent care of newly diagnosed disease or continuation of maintenance therapy that is medically necessary
Brand names: Soliris
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 10 mg/mL |
VIEW MORE immunosuppressive agents, immunologic agents, selective immunosuppressants
CLASS
CLASS
m00104, m00254, m00444
High Alert Drug
: Policy
Last updated: Sep. 9, 2021
- Black Box Warnings: Meningococcal Infection
- FDA REMS: View FDA REMS Info
- FDA REMS: FDA Med Guide Comprehensive List
Policies and procedures
Policy & Procedure System_RX102 Monoclonal Antibody Dose Rounding
Key points:
Consults, protocols, and therapeutic interchanges
Additional information